Horizon Technology Finance Corp
HRZNAnalytical Summary
Horizon Technology Finance Corp faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.
25-Year Financial Trajectory
QuarterlyBullish Indicators
- No bullish signals detected.
Bearish Risks
- Debt to EquityDebt to Equity is concerning (bottom quartile)
Health Breakdown
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ | Q4 FY2018 Dec 31, 2018 10-K ↗ | Q4 FY2017 Dec 31, 2017 10-K ↗ | Q4 FY2016 Dec 31, 2016 10-K ↗ | Q4 FY2015 Dec 31, 2015 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M | N/M |
255.0%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-92.3%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
83.3%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-62.3%
Weak
↑
Weak
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
-17.4%
Weak
↑
Weak
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-950.0%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
23.3%
Good
↓
Good
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
54.3%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
76.9%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
7.5%
Fair
Fair
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) | N/M | N/M |
322.1%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-127.5%
Weak
Weak
Year-over-year change in net income |
N/M |
-16.6%
Weak
Weak
Year-over-year change in net income |
N/M | N/M |
63.1%
Excellent
Excellent
Year-over-year change in net income |
N/M | N/M |
-98.0%
Weak
↓
Weak
Declining
Year-over-year change in net income |
50.7%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
77.4%
Excellent
Excellent
Year-over-year change in net income |
-53.1%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) |
-171.6%
Weak
Weak
Year-over-year change in free cash flow |
— | N/M |
-21.5%
Weak
Weak
Year-over-year change in free cash flow |
N/M | — | — | — |
-73.3%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | N/M | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) |
-49.3%
Weak
Weak
Compound annual EPS growth over 3 years |
— |
18.2%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — |
-20.6%
Weak
Weak
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ | Q4 FY2018 Dec 31, 2018 10-K ↗ | Q4 FY2017 Dec 31, 2017 10-K ↗ | Q4 FY2016 Dec 31, 2016 10-K ↗ | Q4 FY2015 Dec 31, 2015 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-15.16x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.45x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.65x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.39x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.62x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.10x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.88x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-5.94x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.47x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.05x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
2.40x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-21.25x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-7.27x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-15.72x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.02x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ | Q4 FY2018 Dec 31, 2018 10-K ↗ | Q4 FY2017 Dec 31, 2017 10-K ↗ | Q4 FY2016 Dec 31, 2016 10-K ↗ | Q4 FY2015 Dec 31, 2015 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
0.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
9.7%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-7.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-7.0%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-3.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.1%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-2.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
-3.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ | Q4 FY2018 Dec 31, 2018 10-K ↗ | Q4 FY2017 Dec 31, 2017 10-K ↗ | Q4 FY2016 Dec 31, 2016 10-K ↗ | Q4 FY2015 Dec 31, 2015 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
1.34x
Caution
↓
Caution
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.49x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.34x
Caution
↓
Caution
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.50x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.53x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.39x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt (USD) | $447.17M | $473.03M | $424.03M | $425.14M | $467.28M | $467.90M | — | — | $452.49M | — | $435.50M | $418.02M | $439.64M | — | $359.01M | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ | Q4 FY2018 Dec 31, 2018 10-K ↗ | Q4 FY2017 Dec 31, 2017 10-K ↗ | Q4 FY2016 Dec 31, 2016 10-K ↗ | Q4 FY2015 Dec 31, 2015 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | $447.17M | $473.03M | $424.03M | $425.14M | $467.28M | $467.90M | — | — | $452.49M | — | $435.50M | $418.02M | $439.64M | — | $359.01M | — | — | — | — | — | — | — | — | — | — |
| Total Equity (USD) | $333.86M | $318.50M | $315.70M | $283.80M | $305.46M | $336.18M | $342.53M | $328.78M | — | $323.98M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Sep 30, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 Dec 31, 2019 10-K ↗ | Q4 FY2018 Dec 31, 2018 10-K ↗ | Q4 FY2017 Dec 31, 2017 10-K ↗ | Q4 FY2016 Dec 31, 2016 10-K ↗ | Q4 FY2015 Dec 31, 2015 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $2.78M | $8.83M | $30.72M | $-20.78M | $-21.44M | $-12.43M | $7.28M | $-9.13M | $8.65M | $-10.66M | $-11.98M | $152.00K | $5.31M | $4.02M | $5.99M | $7.62M | $3.52M | $2.27M | $12.77M | — | — | — | — | — | — |
| Operating Cash Flow (USD) | $-42.13M | $-30.43M | $50.64M | $49.60M | $-13.19M | $-26.14M | $-28.26M | $54.29M | $4.04M | $11.22M | — | — | $12.73M | $-85.42M | — | $-55.38M | $-55.36M | $-2.32M | — | — | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare HRZN against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare HRZN against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for HRZN
No bullish signals detected
Debt to Equity is concerning (bottom quartile)
Percentile Rankings
How HRZN compares to all companies
Compare HRZN with peers
Stack HRZN against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 11 years · 25 quarters